Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of €155.30 million as of April 24, 2025. Its market cap has increased by 0.28% in one year.

Market Cap

155.30M

Enterprise Value

195.94M

Revenue

51.39M

Ranking

n/a

PE Ratio

9.80

Stock Price

€7.63

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 194.15M to 155.30M, a decrease of -20.01%. That is a compound annual growth rate of -1.21%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	155.30M	-16.08%
Dec 30, 2024	185.06M	94.99%
Dec 29, 2023	94.91M	239.07%
Dec 30, 2022	27.99M	0.21%
Dec 30, 2021	27.93M	-20.96%
Dec 30, 2020	35.34M	-66.13%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Merck KGaA	50.72B
Siemens Healthineers AG	49.89B
Fresenius SE & Co. KGaA	21.97B
Bayer Aktiengesellschaft	20.66B
Sartorius Aktiengesellschaft	13.18B
Fresenius Medical Care AG	12.20B
Carl Zeiss Meditec AG	4.95B
Fielmann Group AG	3.66B

Market Cap Rankings